268 related articles for article (PubMed ID: 7774627)
1. Alloreactive natural killer cells in the rat: complex genetics of major histocompatibility complex control.
Naper C; Vaage JT; Lambracht D; Løvik G; Butcher GW; Wonigeit K; Rolstad B
Eur J Immunol; 1995 May; 25(5):1249-56. PubMed ID: 7774627
[TBL] [Abstract][Full Text] [Related]
2. Allospecific recognition of hemic cells in vitro by natural killer cells from athymic rats: evidence that allodeterminants coded for by single major histocompatibility complex haplotypes are recognized.
Vaage JT; Dissen E; Ager A; Fossum S; Rolstad B
Eur J Immunol; 1991 Sep; 21(9):2167-75. PubMed ID: 1716212
[TBL] [Abstract][Full Text] [Related]
3. Control of rat natural killer cell-mediated allorecognition by a major histocompatibility complex region encoding nonclassical class I antigens.
Vaage JT; Naper C; Løvik G; Lambracht D; Rehm A; Hedrich HJ; Wonigeit K; Rolstad B
J Exp Med; 1994 Aug; 180(2):641-51. PubMed ID: 8046337
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of rat natural killer cell activity by major histocompatibility complex class I recognition.
Kraus E; Lambracht D; Wonigeit K; Hünig T
Eur J Immunol; 1996 Nov; 26(11):2582-6. PubMed ID: 8921942
[TBL] [Abstract][Full Text] [Related]
5. Natural killer cell recognition of "self" and "non-self" triggering antigens on normal lymphoblasts.
Hirayama M; Genyea C; Kaplan J
Cell Immunol; 1996 Oct; 173(1):33-48. PubMed ID: 8871599
[TBL] [Abstract][Full Text] [Related]
6. Identification of an inhibitory MHC receptor on alloreactive rat natural killer cells.
Naper C; Ryan JC; Nakamura MC; Lambracht D; Rolstad B; Vaage JT
J Immunol; 1998 Jan; 160(1):219-24. PubMed ID: 9551974
[TBL] [Abstract][Full Text] [Related]
7. Rat interleukin-2-activated natural killer (A-NK) cell-mediated lysis is determined by the presence of CD18 on A-NK cells and the absence of major histocompatibility complex class I on target cells.
Smits KM; Kuppen PJ; Eggermont AM; Tamatani T; Miyasaka M; Fleuren GJ
Eur J Immunol; 1994 Jan; 24(1):171-5. PubMed ID: 7912675
[TBL] [Abstract][Full Text] [Related]
8. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor.
Nakamura MC; Naper C; Niemi EC; Spusta SC; Rolstad B; Butcher GW; Seaman WE; Ryan JC
J Immunol; 1999 Nov; 163(9):4694-700. PubMed ID: 10528166
[TBL] [Abstract][Full Text] [Related]
9. H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by alpha 1/alpha 2 domains.
Sentman CL; Olsson MY; Salcedo M; Höglund P; Lendahl U; Käre K
J Immunol; 1994 Dec; 153(12):5482-90. PubMed ID: 7989750
[TBL] [Abstract][Full Text] [Related]
10. Hybrid resistance in vitro. Possible role of both class I MHC and self peptides in determining the level of target cell sensitivity.
Chadwick BS; Miller RG
J Immunol; 1992 Apr; 148(7):2307-13. PubMed ID: 1545133
[TBL] [Abstract][Full Text] [Related]
11. Lack of F1 anti-parental resistance in H-2b/d F1 hybrids devoid of beta2-microglobulin.
Höglund P; Olsson-Alheim MY; Johansson M; Kärre K; Sentman CL
Eur J Immunol; 1997 Jan; 27(1):342-5. PubMed ID: 9022038
[TBL] [Abstract][Full Text] [Related]
12. NK cells from human MHC class I (HLA-B) transgenic mice do not mediate hybrid resistance killing against parental nontransgenic cells.
Kung SK; Su RC; Graham JJ; Chamberlain JW; Miller RG
J Immunol; 1998 Jan; 160(2):674-80. PubMed ID: 9551902
[TBL] [Abstract][Full Text] [Related]
13. Partial NK cell tolerance induced by radioresistant host cells in rats transplanted with MHC-mismatched bone marrow.
Naper C; Kveberg L; Engh E; Nestvold J; Rolstad B; Vaage JT
Int Immunol; 2010 Dec; 22(12):973-80. PubMed ID: 21118904
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous alloreactivity of natural killer (NK) and lymphokine-activated killer (LAK) cells from athymic rats against normal haemic cells. NK cells stimulate syngeneic but inhibit allogeneic haemopoiesis.
Rolstad B; Benestad HB
Immunology; 1991 Sep; 74(1):86-93. PubMed ID: 1937576
[TBL] [Abstract][Full Text] [Related]
15. Use of anti-HLA antibodies to mask major histocompatibility complex gene products on tumor cells can enhance susceptibility of these cells to lysis by natural killer cells.
Lobo PI; Spencer CE
J Clin Invest; 1989 Jan; 83(1):278-87. PubMed ID: 2463268
[TBL] [Abstract][Full Text] [Related]
16. Role of non-RT1 genes in the response of rat lymphocytes to Mycoplasma arthritidis T cell mitogen, concanavalin A and phytohemagglutinin.
Cole BC; Griffiths MM; Sullivan GJ; Ward JR
J Immunol; 1986 Apr; 136(7):2364-9. PubMed ID: 3081642
[TBL] [Abstract][Full Text] [Related]
17. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
Karlhofer FM; Ribaudo RK; Yokoyama WM
Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
19. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z
Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
[TBL] [Abstract][Full Text] [Related]
20. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
